Chronic Cough Linked to GLP-1 Medications: What Patients Need to Know

Recent reports indicate a potential increase in chronic cough among individuals taking glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications commonly used for type 2 diabetes and weight management. While the exact cause remains unclear, healthcare professionals and patients should be aware of this emerging side effect.

What are GLP-1 Medications?

GLP-1 receptor agonists mimic the effects of the naturally occurring GLP-1 hormone, which helps regulate blood sugar levels and promotes feelings of fullness. These medications are often prescribed to improve glycemic control in people with type 2 diabetes and, increasingly, for weight loss. Popular GLP-1 medications include semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda).

The Link to Chronic Cough

Reports of chronic cough as a side effect of GLP-1 medications have been increasing, prompting investigation into the potential connection. The nature of the cough varies, but it is generally described as persistent and non-productive – meaning it doesn’t produce mucus. The duration of the cough also varies among individuals.

What is Currently Known?

Currently, the underlying mechanism causing this cough is not fully understood. Researchers are exploring several possibilities, including potential effects on the respiratory system or inflammatory responses. Medscape Medical News reports that rates of this side effect appear to be increasing, but a definitive explanation is still pending.

What Should Patients Do?

If you are taking a GLP-1 medication and develop a novel, persistent cough, it is crucial to consult with your healthcare provider. They can evaluate your symptoms, rule out other potential causes of cough (such as respiratory infections or allergies), and determine the best course of action. Do not stop taking your medication without first discussing it with your doctor.

Are Statins Related?

It’s important to note that this cough is distinct from side effects associated with other medications, such as statins. A recent study, published February 9, 2026, found that the benefits of statins far outweigh the risks of side effects for most patients Medscape.

Staying Informed

The medical community continues to monitor this potential side effect of GLP-1 medications. For the latest medical news, clinical trial coverage, and drug updates, resources like Medscape provide valuable information for both healthcare professionals and patients.